Scholarlink

Background <p>Hypoglycemia is a relevant and rare clinical condition in non-diabetic patients, particularly when associated with neoplasms.</p> Case presentation <p>This case report describes an 80-year-old woman with no significant medical history who presented to the emergency department with marked asthenia and a capillary blood glucose level of 37 mg/dL. During hospitalization, recurrent hypoglycemic episodes were documented, with suppressed insulin and C-peptide levels. Abdominal computed tomography revealed two pancreatic lesions with extensive hepatic metastases. Liver biopsy confirmed a well-differentiated pancreatic neuroendocrine tumor with a Ki-67 index of 3%. Laboratory evaluation revealed markedly suppressed IGF-1 levels and an elevated IGF-2:IGF-1 ratio, consistent with non-islet cell tumor hypoglycemia (NICTH). The patient responded well to prednisolone therapy and was subsequently discharged. She was then referred to the Oncology department and started on octreotide therapy.</p> Conclusion <p>NICTH is a rare and often underdiagnosed paraneoplastic syndrome with significant clinical implications. This case report highlights the importance of considering this entity in patients with unexplained hypoglycemia and emphasizes the crucial role of laboratory and imaging studies in identifying the underlying malignancy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Paraneoplastic hypoglycemia as the initial presentation of a pancreatic neuroendocrine tumor

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月25日

查看全文
  • Inês Farinha Quinteiro,
  • Rita Joana Santos,
  • Ana Luísa Barbosa,
  • Ana Gradil

摘要

Background

Hypoglycemia is a relevant and rare clinical condition in non-diabetic patients, particularly when associated with neoplasms.

Case presentation

This case report describes an 80-year-old woman with no significant medical history who presented to the emergency department with marked asthenia and a capillary blood glucose level of 37 mg/dL. During hospitalization, recurrent hypoglycemic episodes were documented, with suppressed insulin and C-peptide levels. Abdominal computed tomography revealed two pancreatic lesions with extensive hepatic metastases. Liver biopsy confirmed a well-differentiated pancreatic neuroendocrine tumor with a Ki-67 index of 3%. Laboratory evaluation revealed markedly suppressed IGF-1 levels and an elevated IGF-2:IGF-1 ratio, consistent with non-islet cell tumor hypoglycemia (NICTH). The patient responded well to prednisolone therapy and was subsequently discharged. She was then referred to the Oncology department and started on octreotide therapy.

Conclusion

NICTH is a rare and often underdiagnosed paraneoplastic syndrome with significant clinical implications. This case report highlights the importance of considering this entity in patients with unexplained hypoglycemia and emphasizes the crucial role of laboratory and imaging studies in identifying the underlying malignancy.